New user? Sign up here |
Search
Close

Biktarvy and LTBI Treatment Options

Details

Starts at: August 5, 2022 10:00am ET
Ends at: August 5, 2022 10:30am ET
Free Admission

Description

Patient on Biktarvy taken off secondary to elevation of Scr 6.45. 

Other co-morbid conditions present. 

Normalized renal function, restart of Biktarvy. TB-Quantiferon positive (Chest X-ray negative). 

Treatment options for LTBI in light of interactions and any new data based on guidelines. 

Materials

Topics

A variety of the listed topics will be discussed at this event.

  • Other biomedical prevention
  • Adult and adolescent antiretroviral treatment
  • Antiretroviral treatment adherence, including viral load suppression
  • HIV monitoring and lab tests (i.e. CD4 ad viral load)
  • LTBI, drug interactions
  • Hepatitis B
  • Hepatitis C
  • Tobacco cessation
  • Tuberculosis
  • Health literacy
  • Use of technology (i.e. electronic health records)